HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.

AuthorsB R Agarwal, A Gulvady, K Joshi, S Khemani, Z E Currimbhoy
JournalIndian pediatrics (Indian Pediatr) Vol. 32 Issue 9 Pg. 1002-4 (Sep 1995) ISSN: 0019-6061 [Print] India
PMID8935266 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
Topics
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Fatal Outcome
  • Humans
  • Infant
  • Interferon alpha-2
  • Interferon-alpha (administration & dosage, therapeutic use)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (diagnosis, drug therapy, physiopathology)
  • Male
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: